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Abstract Overlay and co-sedimentation assays using recombi-
nant K1-syntrophin proteins revealed that two regions of K1-
syntrophin, i.e. aa 274^315 and 449^505, contain high-affinity
binding sites for F-actin (Kd 0.16^0.45 WM), although only a
single high-affinity site (Kd 0.35 WM) was detected in the
recombinant full-length syntrophin. We also found that acto-
myosin fractions prepared from both cardiac and skeletal muscle
contain proteins recognized by anti-syntrophin antibody. These
data suggest a novel role for syntrophin as an actin binding
protein, which may be important for the function of the
dystrophin-glycoprotein complex or for other cell functions.
We also found that K1-syntrophin binds calmodulin at two
distinct sites with high (Kd 15 nM) and low (Kd 0.3 WM) affinity.
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Key words: Syntrophin; Actin binding; Calmodulin binding;
Dystrophin; Cardiac muscle; Skeletal muscle
1. Introduction
Syntrophin is a peripheral membrane protein ¢rst identi¢ed
in the postsynaptic membrane of Torpedo electric organ [1].
Subsequently, it was found to be associated with dystrophin,
the protein product of the Duchenne muscular dystrophy gene
[2^4]. In skeletal muscle, dystrophin and syntrophin are
present at the peripheral sarcolemma and neuromuscular
junction, whereas they are associated with the peripheral sar-
colemma and T-tubule membranes in cardiac muscle [5^7]. In
these striated muscles, dystrophin and syntrophin form a tight
complex with other dystrophin-associated proteins, many of
which are integral membrane glycoproteins [5,8]. The function
of the dystrophin complex is not known, but it is thought to
mechanically stabilize sarcolemma by linking the actin cyto-
skeleton with the extracellular matrix, since dystrophin and K-
dystroglycan, an extracellular component of the complex,
bind actin and laminin, respectively [9^11].
The syntrophins are a multigene family of homologous pro-
teins comprising three isoforms, K1, L1, and L2, which share
V50% amino acid identity [4,12]. K1-Syntrophin is expressed
primarily in striated muscle, whereas L-syntrophins are ubiq-
uitous in mammalian tissues. All known syntrophins contain
two pleckstrin homology (PH) domains, a PDZ domain ho-
mologous to the postsynaptic density 95 kDa protein, and the
syntrophin unique domain (SU) [4,12]. The PDZ domain is
inserted into and interrupts the ¢rst PH domain. This domain
structure suggests that syntrophins may associate with the
membrane or membrane cytoskeleton and play an important
role in the signal transduction involving the dystrophin-glyco-
protein complex or related structures. However, the precise
function of syntrophins is currently unknown.
Recently syntrophin has been reported to interact with sev-
eral proteins. It binds to a protein sequence derived from
exons 73 and 74 of dystrophin as well as to homologous seg-
ments of utrophin and dystrobrevin [2^4]. Syntrophin self-as-
sociates or associates with other syntrophin [13]. It interacts
with nitric oxide synthase via its PDZ domain in skeletal
muscle [14] and has been reported to bind CaM [15]. In the
present study, we present evidence that F-actin binds to syn-
trophin. We identi¢ed the binding sites for actin and CaM
within the K1-syntrophin molecule.
2. Materials and methods
2.1. Plasmid construction, and protein expression and puri¢cation
For the isolation of K1-syntrophin cDNA, poly(dT)13 primed ¢rst
strand cDNA was synthesized using a SuperScript reverse transcrip-
tase (Gibco BRL) from total RNA (2 Wg) prepared from rabbit skel-
etal muscle and then ampli¢ed by PCR using the following primers:
sense, 5P-TCGGTTGCGACCCGGGGGCTC-3P (nt 331 to 311 of
K1-syntrophin [16]) and antisense, 5P-GGCTCTCTGAGCACCTCA-
3P (nt 1623^1644 of K1-syntrophin [16]). The PCR product was then
cloned into the pGEM-T vector (Promega) and its DNA sequence
determined. A series of MBP or GST fusion protein constructs (see
Fig. 2A) were generated by PCR using K1-syntrophin cDNA as a
template and appropriate primers. Except for the primers described
below, sense primers were designed to exogenously contain a BamHI
restriction site, whereas antisense primers were designed to contain an
in-frame stop codon (TAA) and an exogenous SalI or XhoI site. In
the case of G178^273 and G178^505 fusion protein constructs, an
endogenous EcoRI site of rabbit cDNA was used as the sense primer.
For a v316^365 fusion protein construct, two PCR products corre-
sponding to aa 274^315 and aa 366^448 were ¢rst generated using an
antisense primer exogenously containing a HindIII restriction site (for
aa 274^315) and a sense primer exogenously containing a HindIII
restriction site (for aa 366^448) and then they were ligated with
each other. After restriction enzyme digestion, all these fusion protein
constructs were inserted into the BamHI-SalI site of pMAL-c vector
(New England Biolabs) or the BamHI-SalI or EcoRI-XhoI site of
pGEX-4T3 vector (Pharmacia). Soluble fusion proteins were puri¢ed
from transformed Escherichia coli (HB101 strain from Takara) ac-
cording to the manufacturer’s protocol.
2.2. Preparation of actomyosin and actin
Actomyosin from hamster ventricle was isolated from the post-mi-
crosomal supernatant from high salt extract of muscle homogenates.
Brie£y, ventricle (0.2 g) was homogenized for 30 s three times with
Physcotron NS-10 at 25 000 rpm in 2 ml of bu¡er A (0.6 M NaCl and
10 mM NaHCO3 containing a mixture of protease inhibitors [17]),
kept for 15 min at room temperature, and then centrifuged at 5500Ug
for 20 min. The supernatant was recentrifuged at 100 000Ug for 40
min. The supernatant was then diluted 10-fold with ice-cold H2O and
the resultant pellet was solubilized with bu¡er A. Actomyosin-con-
taining fractions were puri¢ed by repeating this dilution/solubilization
procedure three times. The actomyosin fraction was also prepared
from hamster skeletal muscle by the same method. Puri¢ed actin
was prepared from rabbit skeletal muscle acetone powder as described
by Spudich and Watt [18]. This actin was used in all experiments
except for the one shown in Fig. 1. For the latter, we used actin
prepared from hamster ventricle muscle acetone powder.
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2.3. F-actin co-sedimentation assay
F-actin (2.5 WM) was incubated with various concentrations of GST
or MBP fusion proteins in 60 Wl of actin binding bu¡er (2 mM Tris-
HCl, pH 8.0, 1.0 mM ATP, 0.2 mM CaCl2, 2 mM MgCl2, 100 mM
NaCl, and 0.5 mM L-mercaptoethanol) for 30 min at room temper-
ature. For the full-length syntrophin fusion protein (M1^505), 0.5%
Triton X-100 was included in actin binding bu¡er to avoid protein
aggregation. The samples were then subjected to centrifugation at
100 000Ug for 40 min. Supernatants were carefully decanted and pel-
lets redissolved in an equivalent volume of actin binding bu¡er. To
quantify the fusion proteins bound to F-actin, equal volumes of ali-
quots were taken from the supernatants and resuspended pellets, re-
spectively and were subjected to SDS-PAGE on a 9% gel. CBB-
stained gels were analyzed on a densitometer (Pharmacia LKB, Ul-
troscan II).
2.4. Other procedures
Immunoblot analysis and blot overlay assay were performed as
previously described [19]. In the latter assay, bound fusion proteins
or actin were detected with anti-MBP or anti-actin antibody, respec-
tively. Binding of fusion proteins to CaM-Sepharose beads and £uo-
rescence measurement of dansyl-CaM were measured as described in
detail previously [20]. Data ¢tting was performed by least squares
analysis using the GraphPad Prism software.
2.5. Antibodies and other materials
Monoclonal anti-syntrophin antibody SYN1351, which recognizes
all three isoforms of syntrophin, was a gift from Dr. Stanley C.
Froehner [21]. Preparation of polyclonal anti-L-dystroglycan
(pAb43) antibody was described in [19]. We also used anti-dystrophin
(NCL-DYS2) and anti-K-actin (BioMakor) monoclonal antibodies
and anti-GST (Sigma) and anti-MBP (New England Biolabs) poly-
clonal antibodies. Peptides corresponding to aa 87^105 and aa 106^
126 of K1-syntrophin were synthesized. These peptides were s 95%
pure as determined by high pressure liquid chromatography.
3. Results
We isolated an actomyosin fraction from post-microsomal
supernatants from high salt extracts of hamster ventricular
muscle homogenates. This fraction predominantly contained
myosin (V200 kDa) and actin (V40 kDa), but other proteins
were also present as seen in the CBB-stained gel (Fig. 1).
Immunoblot analysis revealed that this fraction contained 57
and 60^62 kDa proteins recognized by anti-syntrophin anti-
body (Fig. 1, IB:syn). These proteins have electrophoretic
mobilities equivalent to those of syntrophins present in the
dystrophin-glycoprotein complex puri¢ed from hamster ven-
tricular muscle [19]. In the same actomyosin fraction, how-
ever, no protein band reactive with anti-dystrophin or anti-L-
dystroglycan antibody was detected (data not shown), indicat-
ing that the dystrophin-glycoprotein complex is not present in
this fraction. We obtained essentially the same results with the
actomyosin fraction obtained from hamster skeletal muscle
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Fig. 1. Syntrophin binds actin in actomyosin. Actomyosin fraction
(AM) and actin (A) puri¢ed from hamster ventricle muscle were
subjected to SDS-PAGE on a 9% gel followed by blot overlay assay
with a MBP fusion protein (M1^505) (see Fig. 2A) or by immuno-
blot analysis with anti-syntrophin antibody.
Fig. 2. Schematic representation of fusion protein constructs and overlay assay of their actin binding. A: Syntrophin sequences produced as
MBP or GST fusion proteins are shown together with the domain structure of K1-syntrophin. Numbers represent those for the amino acids of
K1-syntrophin. The results from co-sedimentation assay for actin binding and from CaM-Sepharose binding assay are summarized on the right
for each fusion protein. B: Typical SDS-PAGE patterns for representative fusion proteins stained with CBB (CBB) and the results of overlay
assay with 5 Wg/ml F-actin (Overlay) are shown.
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(data not shown). We found that a recombinant full-length
K1-syntrophin speci¢cally bound to a protein of 40 kDa in the
actomyosin fraction (Fig. 1, overlay). This 40 kDa protein is
actin, because the same fusion protein bound to actin puri¢ed
from cardiac (Fig. 1, overlay) or skeletal muscle (data not
shown) and because conversely actin bound to the fusion
protein (Fig. 2B, M1^505). These data provide evidence that
K1-syntrophin binds actin.
We used GST or MBP fusion proteins containing various
portions of K1-syntrophin to de¢ne actin binding sites in this
protein. The fusion protein constructs used are schematically
shown in Fig. 2A along with functional domains of K1-syn-
trophin proposed previously [4,12]. Fig. 2B shows CBB stain-
ing of representative fusion proteins after SDS-PAGE (CBB)
and the results of the overlay assay with F-actin (Overlay).
Actin bound to the fusion proteins containing the PH2
(M274^448) or SU domains (M449^505), whereas it did not
interact with fusion proteins containing PH1a, PDZ, or PH1b
domains (M1^86, G87^177, or G178^273). GST or MBP pro-
tein alone did not associate with actin (data not shown).
F-actin co-sedimentation assay con¢rmed these results.
M1^505, M274^348 or M359^505 was speci¢cally co-precipi-
tated with F-actin (Fig. 3A). Fig. 3B shows Scatchard plots of
the binding of these fusion proteins to F-actin. From the
observed linear plots, single classes of binding site with max-
imal binding of 0.60 þ 0.09, 0.97 þ 0.04 and 1.04 þ 0.06 mol/
mol actin (n = 3) and apparent dissociation constants (Kd) of
0.35 þ 0.10, 0.16 þ 0.01 and 0.45 þ 0.07 WM (n = 3) were esti-
mated for M1^505, M274^348 and M359^505, respectively.
Thus these fusion proteins bind actin at a stoichiometry of
about 1:1 with high a⁄nity, although the stoichiometry for
M1^505 is smaller (0.6). It appears that only a single site is
available in the recombinant full-length syntrophin. We per-
formed F-actin co-sedimentation assay of fusion proteins con-
taining shorter segments of M274^348 and M359^505 and the
results are summarized in Fig. 2A together with those ob-
tained with other fusion proteins. We found that v316^365,
but not M359^448, binds F-actin and that M449^505 also
binds F-actin (Fig. 2A, data not shown). These data indicate
that the N-termini of the PH2 domain (aa 274^315) and the
SU domain (aa 449^505) of K1-syntrophin contain binding
sites for F-actin (Fig. 2A).
Many actin binding proteins contain CaM binding sites.
Using the above fusion proteins, we tested whether K1-syntro-
phin binds CaM. Fusion proteins containing full-length K1-
syntrophin (M1^505), PH1a (M1^86), and PDZ domain
(G87^177) bound to CaM-Sepharose in the presence of
Ca2 and then were eluted with EGTA (Fig. 4A). We also
analyzed binding of CaM to fusion proteins by measurement
of £uorescence emission spectra of dansyl-CaM. M1^505,
M1^86, and G87^177 increased the dansyl-CaM £uorescence
with a concomitant blue shift of spectrum only in the presence
of Ca2 (Fig. 4B and data not shown). In contrast, G178^273,
M274^448, and M449^505 did not bind to CaM-Sepharose or
dansyl-CaM (Fig. 4A and data not shown).
To localize the CaM binding sites more precisely, shorter
segments of M1^86 and G87^177 were tested for their binding
to CaM-Sepharose and the results are summarized in Fig. 2A
together with data obtained with other fusion proteins. We
found that M1^38 and M87^126 bound to CaM-Sepharose
and also increased dansyl-CaM £uorescence (data not shown).
Fig. 4C shows Scatchard plots of the binding of M1^38 and
M87^126 to dansyl-CaM as monitored by an increase in the
£uorescence intensity in 0.1 mM CaCl2. M87^126 bound
CaM with high a⁄nity (Kd 15 nM) (Fig. 4C). A similar Kd
value of 20 nM was obtained from another experiment. With
M1^38, the maximal £uorescence was not reached even at the
highest concentration used (2 WM) (data not shown), indicat-
ing its low a⁄nity for CaM. If we assume that the maximal
£uorescence induced by M1^38 was the same as that by M87^
126, Kd values of 0.30 and 0.33 WM for CaM could be esti-
mated with M1^38 in two di¡erent experiments. To further
narrow down the CaM binding site in M87^126, we prepared
two synthetic peptides (peptides 87^105 and 106^126) based
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Fig. 3. Co-sedimentation of syntrophin fusion proteins with F-actin.
A: Typical CBB-stained gel patterns of the supernatants (S) and the
pellets (P) that were obtained by centrifugation of syntrophin fusion
proteins (0.2 mg/ml each) incubated with or without 4 WM F-actin.
The result obtained with F-actin alone is also shown in the lower
right panel. The positions of fusion protein (b) and actin (U) are
indicated. B: Scatchard plots for binding of MBP1^505 (0.3^3 WM),
MBP274^448 (0.3^2.7 WM) and MBP359^505 (0.5^3 WM) to F-actin
(2.5 WM). The amounts of free and bound proteins were quanti¢ed
by densitometry of CBB-stained gels (see A).
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on the sequence of K1-syntrophin [16]. Peptide 106^126 in-
creased £uorescence of dansyl-CaM in a concentration-de-
pendent manner and Kd values of 15 and 16 nM, which are
close to that for M87^126, were estimated for this peptide
from the Scatchard analysis in two independent experiments
(cf. Fig. 4C, data not shown). Peptide 87^105, however, did
not increase the £uorescence of dansyl-CaM. Thus, a 20 ami-
no acid segment in the PDZ domain (aa 106^126) and the N-
terminus of the PH1a domain (aa 1^38) of K1-syntrophin
were identi¢ed as high- and low-a⁄nity CaM binding sites,
respectively.
We measured binding of various concentrations of full-
length K1-syntrophin fusion protein (M1^505) to dansyl-
CaM and the results were analyzed as in Fig. 4C. Scatchard
plots were biphasic and were ¢tted well by non-linear least
squares analysis to a simple two-independent-site equation
with Kd values of 0.02 and 0.3 WM for the two sites (data
not shown). For CaM, therefore, two binding sites in aa
106^126 and aa 1^38 function independently in the recombi-
nant full-length K1-syntrophin.
4. Discussion
The present results demonstrate that K1-syntrophin has
high-a⁄nity binding sites for F-actin and CaM. In skeletal
and cardiac muscle, K1-syntrophin is known to be a compo-
nent of the dystrophin-glycoprotein complex whose integrity
is critically important for maintaining the viability of sarco-
lemma [22]. This is the ¢rst report providing evidence that K1-
syntrophin binds actin isolated from either skeletal or cardiac
muscle. The actin binding sites are within a short N-terminal
segment containing part of a PH domain (aa 274^315) and a
SU domain (aa 449^505) (Fig. 2A), and their binding a⁄nities
are 0.16 and 0.45 WM, respectively, which are comparable to
or even higher than those of other actin-binding proteins such
as dystrophin (Kd = 1^5 WM) [11,23], utrophin (Kd = 4 WM)
[24], and K-actinin (Kd = 0.6 WM) [25]. Interestingly, these
binding sites of K1-syntrophin do not exhibit homology to
those from other actin binding proteins [26]. It is also inter-
esting to note that only a single class of binding site for F-
actin was detected in the fusion protein containing full-length
syntrophin (Fig. 3B). Thus the two high-a⁄nity actin binding
sites described above do not work simultaneously in the full-
length protein. To clarify how this happens, we need further
experiments using both the recombinant and native syntro-
phin proteins.
We found by immunoblot analysis that the actomyosin
fractions isolated from hamster skeletal and cardiac muscle
contain more than one protein reactive with the anti-syntro-
phin antibody that is able to recognize all isoforms of syntro-
phin (Fig. 1 and Section 3). Since these proteins have electro-
phoretic mobilities equivalent to those recognized by the same
antibody in the dystrophin-glycoprotein complex puri¢ed
from the same tissue [19], it is likely that other syntrophin
isoforms also bind actin. This interpretation is consistent
with the fact that at least one of the deduced actin binding
sites, i.e. the SU domain, is highly conserved in all three iso-
forms of syntrophin [4,12].
It has been widely postulated that the dystrophin-glycopro-
tein complex mechanically stabilizes sarcolemma by linking
the cytoskeleton to the extracellular matrix (see Section 1).
The N-terminal region of dystrophin has been shown to in-
teract directly with F-actin [10,11,23]. Our present ¢nding may
thus suggest that syntrophin by binding actin also helps
strengthen the linkage between the cytoskeleton and the ex-
tracellular matrix, because it is a component of the dystro-
phin-glycoprotein complex. On the other hand, the actomyo-
sin fraction contained proteins immunoreactive with anti-
syntrophin antibody as described above, whereas the same
fraction contained no proteins reactive with anti-dystrophin
or anti-L-dystroglycan antibody (Fig. 1 and see Section 3).
Since only mild procedures were used to isolate the actomyo-
sin fraction in this study (see Section 2), the result suggests
that syntrophin may normally also occur in a pool of proteins
containing actomyosin which is distinct from that containing
the dystrophin-glycoprotein complex. This interpretation is
consistent with our recent ¢nding that by immuno£uorescence
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Fig. 4. CaM binding assay of fusion proteins. A: CaM-Separose
beads (100 Wl) were incubated with fusion proteins (10 Wg each) in
100 Wl of bu¡er containing 0.1 mM CaCl2, 10 mM HEPES/Tris
(pH 7.2) and 100 mM NaCl and then washed extensively. Proteins
were subsequently eluted from beads with 100 Wl of bu¡er contain-
ing 5 mM EGTA. The £ow through fraction (20 Wl) (lane 1) and
the EGTA eluate (20 Wl) (lane 2) were subjected to SDS-PAGE and
stained with CBB. B: Fluorescence emission spectra of 0.2 WM dan-
syl-CaM in the presence of 0.1 mM CaCl2 and either 0, 0.2 and 1.4
WM M87^177 measured with excitation at 340 nm. C: Scatchard
analysis of binding of syntrophin fusion proteins to dansyl-CaM as
monitored by an increase in the £uorescence intensity at 490 nm as
previously described [20].
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anti-syntrophin antibody produced a regular striation pattern
overlapping the staining with anti-K-actinin antibody in lon-
gitudinal sections of hamster skeletal muscle (Y. Iwata et al.,
unpublished observation). This latter ¢nding suggests that
syntrophin colocalizes with K-actinin on the Z lines. Inde-
pendent behavior of dystrophin and syntrophin (Mr 58 000
protein) was also noted previously by Butler et al. [6] when
each was immunoisolated using a speci¢c antibody from Tri-
ton X-100 extracts of Torpedo postsynaptic membranes.
We identi¢ed two CaM binding sites in K1-syntrophin, one
(aa 106^126) with high a⁄nity and localized within a PDZ
domain and the other (aa 1^38) with low a⁄nity and localized
in a PH (PH1a) domain (Fig. 2A). These binding sites func-
tion independently in the recombinant full-length K1-syntro-
phin because the binding curve could be ¢tted by assuming
two classes of independent binding site with Kd values of the
above high- and low-a⁄nity sites (see Section 3). Both these
CaM binding sites have all the features expected of a typical
CaM binding segment; by using the algorithm developed by
Erickson-Viitanen and DeGrado [27], the hydrophobic mo-
ments of amino acid sequences aa 17^34 and aa 108^125
were calculated to be 0.64 and 0.66, respectively and the
mean hydrophobicity of these segments to be 30.03 and
30.06, respectively. CaM binding to the sites in the PDZ
and PH domains is interesting, because these modules may
allow proteins containing these modules to associate with oth-
er membrane or cytosolic proteins directly or via an interac-
tion with phosphatidylinositol lipids [28,29]. CaM could po-
tentially modulate the function of these putative signaling
modules in K1-syntrophin.
Using fusion proteins, Newbell et al. [15] have recently
studied CaM binding to K1-syntrophin. They reported that
an N-terminal region (aa 4^173) bound CaM both in the
presence and absence of Ca2 with relatively low a⁄nity
(Kd 100 nM), whereas a 24 aa segment at the C-terminus
(aa 480^503) bound CaM with high a⁄nity (Kd 20^30 nM).
These data are not consistent with the present ¢ndings which
show that the N-terminal region contains high- and low-a⁄n-
ity sites to which CaM binds in a strictly Ca2-dependent
manner and that the fusion proteins containing the SU do-
main (M449^505) does not bind CaM. At present, we have no
explanation for these di¡erences.
Acknowledgements: We thank Drs. Hirofumi Onishi and Shin-ichirou
Kojima for a generous gift of skeletal actin. We also thank Dr. Stan-
ley C. Froehner for a gift of SYN1351. This work was supported by a
grant from the Cardiovascular Research Foundation.
References
[1] Froehner, S.C. (1984) J. Cell Biol. 99, 88^96.
[2] Kramarcy, N.R., Vidal, A., Froehner, S.C. and Sealock, R.
(1994) J. Biol. Chem. 269, 2870^2876.
[3] Suzuki, A., Yoshida, M., Hayashi, K., Mizuno, Y., Hagiwara, Y.
and Ozawa, E. (1994) Eur. J. Biochem. 220, 283^292.
[4] Ahn, A.H., Freener, C.A., Gussoni, E., Yoshida, M., Ozawa, E.
and Kunkel, L.M. (1996) J. Biol. Chem. 271, 2724^2730.
[5] Ervasti, J.M. and Campbell, K.P. (1991) Cell 66, 1121^1131.
[6] Butler, M.H., Douville, K., Murnane, A.A., Kramarcy, N.R.,
Cohen, J.B., Sealock, R. and Froehner, S.C. (1992) J. Biol.
Chem. 267, 6213^6218.
[7] Klietsch, R., Ervasti, J.M., Arnold, W., Campbell, K.P. and Jor-
gensen, A.O. (1993) Circ. Res. 72, 349^360.
[8] Yoshida, M. and Ozawa, E. (1990) J. Biochem. 108, 748^752.
[9] Ervasti, J.M. and Campbell, K.P. (1993) J. Cell Biol. 122, 809^
823.
[10] Hemmings, L., Kuhlman, P.A. and Critchley, D.R. (1992) J. Cell
Biol. 116, 1369^1380.
[11] Way, M., Pope, B., Cross, R.A., Kendrick-Jones, J. and Weeds,
A.G. (1992) FEBS Lett. 301, 243^245.
[12] Adams, M.E., Dwyer, T.M., Dowler, L.L., White, R.A. and
Froehner, S.C. (1995) J. Biol. Chem. 270, 25859^25865.
[13] Yang, B., Jung, D., Rafael, J.A., Chamberlain, J.S. and Camp-
bell, K.P. (1995) J. Biol. Chem. 270, 4975^4978.
[14] Brenman, J.E., Chao, D.S., Gee, S.H., McGee, A.W., Craven,
S.E., Santillano, D.R., Wu, Z., Huang, F., Xia, H., Peters, M.F.,
Froehner, S.C. and Bredt, D.S. (1996) Cell 84, 757^767.
[15] Newbell, B.J., Anderson, J.T. and Jarrett, H.W. (1997) Biochem-
istry 36, 1295^1305.
[16] Yang, B., Ibraghimov-Beskrovnaya, O., Moomaw, C.R., Slaugh-
ter, C.A. and Campbell, K.P. (1994) J. Biol. Chem. 269, 6040^
6044.
[17] Iwata, Y., Nakamura, H., Fujiwara, K. and Shigekawa, M.
(1993) Biochem. Biophys. Res. Commun. 190, 589^595.
[18] Spudich, J.A. and Watt, S. (1971) J. Biol. Chem. 246, 4866^4871.
[19] Iwata, Y., Pan, Y., Hanada, H., Yoshida, T. and Shigekawa, M.
(1996) J. Mol. Cell. Cardiol. 28, 2501^2509.
[20] Bertrand, B., Wakabayashi, S., Ikeda, T., PousseŁgur, J. and Shi-
gekawa, M. (1994) J. Biol. Chem. 269, 13703^13709.
[21] Froehner, S.C., Murnane, A.A., Tobler, M., Peng, H.B. and
Sealock, R. (1987) J. Cell Biol. 104, 1633^1646.
[22] Campbell, K.P. (1995) Cell 80, 675^679.
[23] Fabbriziro, E., Bonet-Kerrache, A., Leger, J.J. and Monet, D.
(1993) Biochemistry 32, 10457^10463.
[24] Winder, S.J., Hemmings, L., Maciver, S.K., Bolton, S.J., Davies,
K.E., Critchley, D.R. and Kendrick-Jones, J. (1995) J. Cell Sci.
108, 63^71.
[25] Waschsstock, D.H., Schwarz, W.H. and Pollard, T.D. (1993)
Biophys. J. 65, 205^214.
[26] Vandekerckhove, J. and Vancompernolle, K. (1992) Curr. Opin.
Cell Biol. 4, 36^42.
[27] Erickson-Viitanen, S. and DeGrado, W.F. (1987) Methods En-
zymol. 139, 455^478.
[28] Shaw, G. (1996) BioEssays 18, 35^46.
[29] Sheng, M. (1996) Neuron 17, 575^578.
FEBS 19853 20-2-98
Y. Iwata et al./FEBS Letters 423 (1998) 173^177 177
